Navigation Links
Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
Date:12/30/2008

DuPont today announced that the breakthrough bio-based ingredient, Zemea® propanediol, has been independently evaluated by NSF International and now is listed in the CleanGredients® database as passing the U.S. Environmental Protection Agency (EPA) Design for the Environment (DfE) screen. Zemea® is produced and marketed by the DuPont Tate & Lyle Bio Products joint venture.

Loudon, TN (Vocus) December 30, 2008 -- DuPont today announced that the breakthrough bio-based ingredient, Zemea® propanediol, has been independently evaluated by NSF International and now is listed in the CleanGredients® database as passing the U.S. Environmental Protection Agency (EPA) Design for the Environment (DfE) screen. Zemea® is produced and marketed by the DuPont Tate & Lyle Bio Products joint venture.

Zemea® is the first DfE-screened solvent to be listed in CleanGredients®. It is a 100 percent natural ingredient made from corn sugar and developed for use in the cleaning and personal care categories. Zemea® is a sustainable alternative to petroleum-based glycols in cleaning product formulations where the product's solvency properties, purity level, low irritation and excellent moisturization properties are benefits.
   
CleanGredients® is an online database of quality cleaning product ingredients. It helps formulators identify the ingredients they need to help them formulate greener, more sustainable cleaning products. CleanGredients® is a project of nonprofit institute GreenBlue®.

"We're excited to be the first solvent listed in CleanGredients®," said David Wood, product director -- DuPont Tate & Lyle Bio Products. "We share similar objectives with GreenBlue® around quality, sustainability and minimizing our environmental footprint. We believe this listing will enable more formulators to take advantage of the performance benefits of Zemea® and help them to streamline the process for achieving DfE recognition for their cleaning products."

DfE is one of the EPA's premier partnership programs, working with industry sectors to compare and improve the human health and environmental risks - as well as the performance and cost - of existing and alternative products, processes and practices. The DfE provides screens for safer chemicals to identify preferred ingredients. NSF International provides third party reviews for the U.S. EPA DfE formulator program. NSF International is the world leader in standards development, product certification, education and risk-management for public health and safety.
   
DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a world-leading renewable food and industrial ingredients company. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that do not compromise product performance. For more information on the company's products, visit www.duponttateandlyle.com.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont™, The miracles of science™, and Bio-PDO™ are registered trademarks or trademarks of DuPont or its affiliates.

Zemea® is a registered trademark of DuPont Tate & Lyle Bio Products LLC.

CleanGredients® is a registered trademark of GreenBlue.

GreenBlue® is a registered trademark of GreenBlue.

###

Read the full story at http://www.prweb.com/releases/DuPont/Zemea_propanediol/prweb1807494.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
2. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
3. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
4. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
5. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
6. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
7. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
8. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
9. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
10. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
11. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
(Date:3/28/2017)... , March 28, 2017 Biostage, ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, today announced that Jim McGorry, CEO ... and BioEngineering panel at the MassBio 2017 ... 2:30 PM ET in Cambrige, Massachussetts. The 3D ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic ... time. A recent study published in STEM CELLS suggests that human neural stem ... stem cells to produce more neural cells. , Strategies involving transplantation of ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... launch its brand-new, fully-certified hygienic SWB805 MultiMountTM weigh modules. These weigh modules ... and certified by National Sanitation Foundation (NSF). , As fully integrated weighing ...
(Date:3/28/2017)... ... March 28, 2017 , ... T3D ... a new orally administered treatment for Alzheimer’s disease (AD), today announced that Dr. ... “As we seek to uniquely treat the metabolic dysfunctions inherent in Alzheimer’s disease ...
Breaking Biology Technology:
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
Breaking Biology News(10 mins):